CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.08 CNY | -3.70% |
|
-19.07% | -44.23% |
| Sales 2024 * | 56.9B 7.85B | Sales 2025 * | 67.78B 9.35B | Capitalization | 81.58B 11.26B |
|---|---|---|---|---|---|
| Net income 2024 * | 9.06B 1.25B | Net income 2025 * | 12.89B 1.78B | EV / Sales 2024 * | 1.25 x |
| Net cash position 2024 * | 10.68B 1.47B | Net cash position 2025 * | 18.8B 2.59B | EV / Sales 2025 * | 0.93 x |
| P/E ratio 2024 * |
7.64
x | P/E ratio 2025 * |
6.5
x | Employees | 6,545 |
| Yield 2024 * |
1.94% | Yield 2025 * |
2.11% | Free-Float | 14.73% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.70% | ||
| 1 week | -19.07% | ||
| Current month | -24.17% | ||
| 1 month | -27.98% | ||
| 3 months | -30.89% | ||
| 6 months | -38.91% | ||
| Current year | -44.23% |
1 week
33.51
41.18
1 month
33.5147.13
Current year
33.5161.11
1 year
33.5170.27
3 years
33.51154.13
5 years
24.01154.13
10 years
5.35154.13
| Managers | Title | Age | Since |
|---|---|---|---|
Hai Ping Xu
CHM | Chairman | 43 | 13-12-31 |
Zhen Jing Li
DFI | Director of Finance/CFO | 42 | 13-12-31 |
Ren Sheng Jiang
CHM | Chairman | 71 | 09-08-16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ren Sheng Jiang
CHM | Chairman | 71 | 09-08-16 |
Ling Feng Jiang
BRD | Director/Board Member | 44 | 12-07-31 |
Lin Du
BRD | Director/Board Member | 59 | 17-04-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.58% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 34.21 | +0.38% | 27,692,140 |
| 24-04-24 | 34.08 | -3.70% | 47,838,740 |
| 24-04-23 | 35.39 | -11.99% | 78,078,760 |
| 24-04-22 | 40.21 | -0.69% | 15,066,260 |
| 24-04-19 | 40.49 | -2.03% | 20,373,290 |
End-of-day quote Shenzhen S.E., April 23, 2024
More quotes
Chongqing Zhifei Biological Products Co., Ltd. specializes in the research and development of vaccines for human use. The products include, in particular, bacterial vaccines for the prevention of meningitis, tuberculosis, rabies and influenza.
Sector
Pharmaceuticals
Calendar
2024-06-17
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
34.08
CNY
Average target price
64.77
CNY
Spread / Average Target
+90.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -44.23% | 11.26B | |
| -2.86% | 87.31B | |
| +3.95% | 40.86B | |
| -21.94% | 29.36B | |
| +53.93% | 24.49B | |
| -5.41% | 17.31B | |
| -17.60% | 11.62B | |
| -13.96% | 11.31B | |
| +3.60% | 8.31B | |
| +2.09% | 7.63B |
- Stock Market
- Equities
- 300122 Stock
